{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:21:58Z","timestamp":1775683318101,"version":"3.50.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":595,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Med"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1111\/pme.12319","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T11:21:01Z","timestamp":1389698461000},"page":"1072-1082","source":"Crossref","is-referenced-by-count":23,"title":["Immunoglobulin G for the Treatment of Chronic Pain: Report of an Expert Workshop"],"prefix":"10.1093","volume":"15","author":[{"given":"Stefano","family":"Tamburin","sequence":"first","affiliation":[{"name":"Department of Neurological and Movement Sciences; University of Verona; Verona Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Borg","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Department of Clinical Sciences; Karolinska Institute at Danderyds Hospital; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier J.","family":"Caro","sequence":"additional","affiliation":[{"name":"Division of Rheumatology; David Geffen School of Medicine at UCLA; Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Jann","sequence":"additional","affiliation":[{"name":"Department of Neurosciences; Hospital Niguarda C\u00e0 Granda; Milan Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Pain Management and Perioperative Medicine; Dalhousie University; Halifax Nova Scotia Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Magrinelli","sequence":"additional","affiliation":[{"name":"Department of Neurological and Movement Sciences; University of Verona; Verona Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[{"name":"Department of Neurology; Nagoya University Graduate School of Medicine; Nagoya Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Werhagen","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation Medicine, Department of Clinical Sciences; Karolinska Institute at Danderyds Hospital; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampietro","family":"Zanette","sequence":"additional","affiliation":[{"name":"Section of Neurology; Pederzoli Hospital; Peschiera del Garda Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Neurology; Nagoya University Graduate School of Medicine; Nagoya Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Sp\u00e4th","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology; University of Bern; Bern Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences; University of Oxford; Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Goebel","sequence":"additional","affiliation":[{"name":"Pain Research Institute; University of Liverpool, Clinical Sciences Building, University Hospital Aintree; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,1,14]]},"reference":[{"issue":"suppl 1","key":"10.1111\/pme.12319-BIB0001|pme12319-cit-0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11630060-000000000-00000","article-title":"The management of chronic pain in important patient subgroups","volume":"32","author":"Cherubino","year":"2012","journal-title":"Clin Drug Investig"},{"issue":"suppl 2","key":"10.1111\/pme.12319-BIB0002|pme12319-cit-0002","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1526-4637.2011.01307.x","article-title":"Treatment guidelines for the pharmacological management of pain in older persons","volume":"13","author":"Fine","year":"2012","journal-title":"Pain Med"},{"key":"10.1111\/pme.12319-BIB0003|pme12319-cit-0003","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"10.1111\/pme.12319-BIB0004|pme12319-cit-0004","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/practneurol-2013-000536","article-title":"Neuropathic pain: Diagnosis and treatment","volume":"13","author":"Magrinelli","year":"2013","journal-title":"Pract Neurol"},{"key":"10.1111\/pme.12319-BIB0005|pme12319-cit-0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1111\/pme.12319-BIB0006|pme12319-cit-0006","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s10875-010-9403-8","article-title":"Immunoglobulin responsive chronic pain","volume":"30","author":"Goebel","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1111\/pme.12319-BIB0007|pme12319-cit-0007","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.pain.2011.06.012","article-title":"Autoimmunity against the \u03b22 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome","volume":"152","author":"Kohr","year":"2011","journal-title":"Pain"},{"key":"10.1111\/pme.12319-BIB0008|pme12319-cit-0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1529-8027.2001.01010.x","article-title":"Etanercept reduces hyperalgesia in experimental painful neuropathy","volume":"6","author":"Sommer","year":"2001","journal-title":"J Peripher Nerv Syst"},{"key":"10.1111\/pme.12319-BIB0009|pme12319-cit-0009","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/jnnp.2007.134528","article-title":"Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies","volume":"79","author":"Ludwig","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/pme.12319-BIB0010|pme12319-cit-0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/01.wnl.0000265062.92340.a5","article-title":"Differential expression of cytokines in painful and painless neuropathies","volume":"69","author":"U\u00e7eyler","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/pme.12319-BIB0011|pme12319-cit-0011","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pain.2007.07.031","article-title":"Differential expression patterns of cytokines in complex regional pain syndrome","volume":"132","author":"U\u00e7eyler","year":"2007","journal-title":"Pain"},{"key":"10.1111\/pme.12319-BIB0012|pme12319-cit-0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2474-12-245","article-title":"Systematic review with meta-analysis: Cytokines in fibromyalgia syndrome","volume":"12","author":"U\u00e7eyler","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1111\/pme.12319-BIB0013|pme12319-cit-0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11916-008-0029-y","article-title":"Status of immune mediators in painful neuropathies","volume":"12","author":"U\u00e7eyler","year":"2008","journal-title":"Curr Pain Headache Rep"},{"key":"10.1111\/pme.12319-BIB0014|pme12319-cit-0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-510X(02)00316-7","article-title":"Prior poliomyelitis-evidence of cytokine production in the central nervous system","volume":"205","author":"Gonzalez","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1111\/pme.12319-BIB0015|pme12319-cit-0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1742-2094-9-167","article-title":"Intravenous immunoglobulin treatment of the post-polio syndrome: Sustained effects on quality of life variables and cytokine expression after one year follow up","volume":"9","author":"Gonzalez","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1111\/pme.12319-BIB0016|pme12319-cit-0016","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2008.03.015","article-title":"Elevated serum inflammatory markers in post-poliomyelitis syndrome","volume":"271","author":"Fordyce","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1111\/pme.12319-BIB0017|pme12319-cit-0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/pme.12319-BIB0018|pme12319-cit-0018","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1526-4637.2009.00704.x","article-title":"Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy","volume":"10","author":"Tamburin","year":"2009","journal-title":"Pain Med"},{"key":"10.1111\/pme.12319-BIB0019|pme12319-cit-0019","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11940-010-0059-8","article-title":"Treatment of diabetic and non diabetic lumbosacral radiculoplexus neuropathy","volume":"12","author":"Thaisetthawatkul","year":"2010","journal-title":"Curr Treat Options Neurol"},{"key":"10.1111\/pme.12319-BIB0020|pme12319-cit-0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.10080","article-title":"Diabetic and non diabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment","volume":"25","author":"Dyck","year":"2002","journal-title":"Muscle Nerve"},{"issue":"suppl 2","key":"10.1111\/pme.12319-BIB0021|pme12319-cit-0021","first-page":"A191","article-title":"The multi-centre double-blind controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy","volume":"66","author":"Dyck","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/pme.12319-BIB0022|pme12319-cit-0022","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/jnnp.2006.111302","article-title":"Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy","volume":"78","author":"Kawagashira","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1111\/pme.12319-BIB0023|pme12319-cit-0023","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006521.pub3","article-title":"Immunotherapy for diabetic amyotrophy","author":"Chan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/pme.12319-BIB0024|pme12319-cit-0024","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1526-4637.2012.01478.x","article-title":"Efficacy and safety of intravenous immunoglobulin as adjuvant treatment for refractory neuropathic pain. Results of an open-label, multicenter study","volume":"13","author":"Jann","year":"2012","journal-title":"Pain Med"},{"key":"10.1111\/pme.12319-BIB0025|pme12319-cit-0025","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jocn.2009.12.013","article-title":"Differential response to intravenous immunoglobulin (IVIg) therapy among multifocal and polyneuropathy types of painful diabetic neuropathy","volume":"17","author":"Kawagashira","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1111\/pme.12319-BIB0026|pme12319-cit-0026","unstructured":"Clinicaltrialsregister.eu [Internet] 2012 March 28-Identifier 2010-023883-42, Randomized, double-blind, placebo controlled trial to evaluate the efficacy of high dose intravenous immunoglobulins in diabetic painful polyneuropathy (DPNP) resistant to conventional therapies 2012 https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2010-023883-42"},{"key":"10.1111\/pme.12319-BIB0027|pme12319-cit-0027","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sj\u00f6gren's syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"10.1111\/pme.12319-BIB0028|pme12319-cit-0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2012.05.022","article-title":"Differential, size-dependent sensory neuron involvement in the painful and ataxic forms of primary Sj\u00f6gren's syndrome associated neuropathy","volume":"319","author":"Kawagashira","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1111\/pme.12319-BIB0029|pme12319-cit-0029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2008.12.018","article-title":"Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sj\u00f6gren's syndrome","volume":"279","author":"Morozumi","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1111\/pme.12319-BIB0030|pme12319-cit-0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4637.2002.02018.x","article-title":"Human pooled immunoglobulin in the treatment of chronic pain syndromes","volume":"3","author":"Goebel","year":"2002","journal-title":"Pain Med"},{"key":"10.1111\/pme.12319-BIB0031|pme12319-cit-0031","unstructured":"ClinicalTrials.gov [Internet] 2009 Feb 18-Identifier NCT00850005, intravenous immunoglobulin (IVIG) for resistant neuropathic pain 2009 http:\/\/clinicaltrials.gov\/show\/NCT00850005"},{"key":"10.1111\/pme.12319-BIB0032|pme12319-cit-0032","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"key":"10.1111\/pme.12319-BIB0033|pme12319-cit-0033","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/pme.12033","article-title":"Complex regional pain syndrome: Practical diagnostic and treatment guidelines","volume":"14","author":"Harden","year":"2013","journal-title":"Pain Med"},{"key":"10.1111\/pme.12319-BIB0034|pme12319-cit-0034","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09629350210307","article-title":"Evidence for local inflammation in complex regional pain syndrome type 1","volume":"11","author":"Huygen","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1111\/pme.12319-BIB0035|pme12319-cit-0035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.autrev.2012.10.015","article-title":"Complex regional pain syndrome, prototype of a novel kind of autoimmune disease","volume":"12","author":"Goebel","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1111\/pme.12319-BIB0036|pme12319-cit-0036","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-152-3-201002020-00006","article-title":"Intravenous immunoglobulin treatment of the complex regional pain syndrome: A randomized trial","volume":"152","author":"Goebel","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1111\/pme.12319-BIB0037|pme12319-cit-0037","unstructured":"Clinicaltrialsregister.eu [Internet] 2012 Sept 14-Identifier 2012-000058-73, A multi-centre (UK) double-blind randomised parallel group placebo controlled trial to evaluate the efficacy, safety, and tolerability of Intravenous Immunoglobulin (IVIg) 0.5\u2009g\/kg plus standard treatment, versus matched placebo plus standard treatment in patients with longstanding complex regional pain syndrome 2012 https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2012-000058-73"},{"key":"10.1111\/pme.12319-BIB0038|pme12319-cit-0038","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/rheumatology\/ket282","article-title":"Immunoglobulin maintenance therapy in long-standing complex regional pain syndrome, an open study","volume":"52","author":"Goebel","year":"2013","journal-title":"Rheumatology"},{"key":"10.1111\/pme.12319-BIB0039|pme12319-cit-0039","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(12)70093-5","article-title":"Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: A randomised controlled trial","volume":"11","author":"Nobile-Orazio","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1111\/pme.12319-BIB0040|pme12319-cit-0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/mcp.2011.0206","article-title":"The science of fibromyalgia","volume":"86","author":"Clauw","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/pme.12319-BIB0041|pme12319-cit-0041","first-page":"146","article-title":"Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia","volume":"30","author":"Salemi","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/pme.12319-BIB0042|pme12319-cit-0042","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain-differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1111\/pme.12319-BIB0043|pme12319-cit-0043","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2004.04.034","article-title":"Symptoms and signs in patients with suspected neuropathic pain","volume":"110","author":"Rasmussen","year":"2004","journal-title":"Pain"},{"key":"10.1111\/pme.12319-BIB0044|pme12319-cit-0044","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/rheumatology\/kem345","article-title":"A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg","volume":"47","author":"Caro","year":"2008","journal-title":"Rheumatology"},{"key":"10.1111\/pme.12319-BIB0045|pme12319-cit-0045","first-page":"S388","article-title":"Evidence of abnormal epidermal nerve fiber density in fibromyalgia","volume":"58","author":"Caro","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/pme.12319-BIB0046|pme12319-cit-0046","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"U\u00e7eyler","year":"2013","journal-title":"Brain"},{"key":"10.1111\/pme.12319-BIB0047|pme12319-cit-0047","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1474-4422(10)70095-8","article-title":"Management of postpolio syndrome","volume":"9","author":"Gonzalez","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1111\/pme.12319-BIB0048|pme12319-cit-0048","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00415-010-5456-0","article-title":"Analysis of long-standing nociceptive and neuropathic pain in patients with post-polio syndrome","volume":"257","author":"Werhagen","year":"2010","journal-title":"J Neurol"},{"key":"10.1111\/pme.12319-BIB0049|pme12319-cit-0049","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jprot.2008.11.014","article-title":"Identification of novel candidate protein biomarkers for the post-polio syndrome-Implications for diagnosis, neurodegeneration and neuroinflammation","volume":"71","author":"Gonzalez","year":"2009","journal-title":"J Proteomics"},{"key":"10.1111\/pme.12319-BIB0050|pme12319-cit-0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2004.01.010","article-title":"Prior poliomyelitis-IVIG treatment reduces proinflammatory cytokine production","volume":"150","author":"Gonzalez","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1111\/pme.12319-BIB0051|pme12319-cit-0051","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(06)70447-1","article-title":"Intravenous immunoglobulin for post-polio syndrome: A randomised controlled trial","volume":"5","author":"Gonzalez","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1111\/pme.12319-BIB0052|pme12319-cit-0052","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2340\/16501977-0884","article-title":"Effect of intravenous immunoglobulin on pain in patients with post-polio syndrome","volume":"43","author":"Werhagen","year":"2011","journal-title":"J Rehabil Med"},{"key":"10.1111\/pme.12319-BIB0053|pme12319-cit-0053","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00415-012-6538-y","article-title":"IVIG treatment in post-polio patients: Evaluation of responders","volume":"259","author":"\u00d6stlund","year":"2012","journal-title":"J Neurol"},{"key":"10.1111\/pme.12319-BIB0054|pme12319-cit-0054","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-1331.2006.01552.x","article-title":"Post-polio syndrome patients treated with intravenous immunoglobulin: A double-blinded randomized controlled pilot study","volume":"14","author":"Farbu","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1111\/pme.12319-BIB0055|pme12319-cit-0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: New developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1111\/pme.12319-BIB0056|pme12319-cit-0056","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: Clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1111\/pme.12319-BIB0057|pme12319-cit-0057","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.0b013e3182698dc3","article-title":"Autoimmune pain: An emerging concept","volume":"79","author":"Bennett","year":"2012","journal-title":"Neurology"},{"key":"10.1111\/pme.12319-BIB0058|pme12319-cit-0058","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1111\/pme.12319-BIB0059|pme12319-cit-0059","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1111\/pme.12319-BIB0060|pme12319-cit-0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","article-title":"Primary immunodeficiency diseases worldwide: More common than generally thought","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1111\/pme.12319-BIB0061|pme12319-cit-0061","first-page":"7","volume-title":"Blood, Plasma and Plasma proteins: A Unique Contribution to Modern Health Care. Pharmaceuticals Policy and Law","author":"Waller","year":"2006"},{"key":"10.1111\/pme.12319-BIB0062|pme12319-cit-0062","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biologicals.2009.01.005","article-title":"Plasma fractionation issues","volume":"37","author":"Farrugia","year":"2009","journal-title":"Biologicals"},{"key":"10.1111\/pme.12319-BIB0063|pme12319-cit-0063","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.beha.2005.01.002","article-title":"Plasma protein therapies: Current and future perspectives","volume":"19","author":"Farrugia","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/pme.12319-BIB0064|pme12319-cit-0064","first-page":"81","volume-title":"Blood, Plasma and Plasma proteins: A Unique Contribution to Modern Health Care. Pharmaceuticals Policy and Law","author":"Jacobson","year":"2006"},{"key":"10.1111\/pme.12319-BIB0065|pme12319-cit-0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1474-4422(13)70014-0","article-title":"Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: A phase 2, randomised, double-blind, placebo-controlled, dose-finding trial","volume":"12","author":"Dodel","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1111\/pme.12319-BIB0066|pme12319-cit-0066","first-page":"161","volume-title":"Health Technology Assessments and Rare Diseases. Pharmaceuticals Policy and Law","author":"Phillips","year":"2011"},{"key":"10.1111\/pme.12319-BIB0067|pme12319-cit-0067","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1182\/blood-2012-03-415695","article-title":"Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fc\u03b3 receptor for the amelioration of experimental ITP","volume":"119","author":"Leontyev","year":"2012","journal-title":"Blood"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpme.12319","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/15\/7\/1072\/5306821\/15-7-1072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T04:17:31Z","timestamp":1503548251000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-lookup\/doi\/10.1111\/pme.12319"}},"subtitle":["Pain Relief with IVIg"],"short-title":[],"issued":{"date-parts":[[2014,1,14]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1111\/pme.12319","relation":{},"ISSN":["1526-2375"],"issn-type":[{"value":"1526-2375","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,14]]}}}